Abstract
The citrullination of arginine is one of the smallest posttranslational modifications made to proteins, by mass. Mass spectrometric methods of analysis offer the potential to not only identify sites of protein citrullination but in some instances to quantify their occurrence in diseased tissue, relative to healthy tissues. This is an emerging, if challenging, area where method and instrument selections can influence not only data quality but also throughput. Citrullination, or deimination of arginine, results in the addition of only 0.9848 Da to a peptide. Recent improvements in the accuracy and resolution of mass spectrometers, as well as the advancement of protein chemistry technology that selectively targets citrulline moieties, has allowed greater success in identifying citrullinated arginine within proteins and peptides. This chapter provides an overview of recent, successful strategies used to identify citrullination sites using modern proteomic methods that involve mass spectrometric analysis. Applications to the study of multiple sclerosis and arthritis are highlighted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anzilotti C, Pratesi F, Tommasi C, Migliorini P (2010) Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun Rev 9(3):158–160
Biemann K (1990) Utility of exact mass measurements. Methods Enzymol 193:295–305
Brand-Schieber E, Werner P, Iacobas DA, Iacobas S, Beelitz M, Lowery SL, Spray DC, Scemes E (2005) Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis. J Neurosci Res 80(6):798–808
Butler AR, Hussain I (1982) Mechanistic studies in the chemistry of urea. J.C.S. Perkins II. 310–316
Comisarow MB, Marshall AG (1974) Fourier transform ion cyclotron resonance spectroscopy. Chem Phys Lett 25:282–283
Cornish TJ, Cotter RJ (1993) Matrix-assisted laser desorption/ionization tandem reflectron time-of-flight mass spectrometry of fullerenes. Anal Chem 65(8):1043–1047
Cotter RJ, Griffith W, Jelinek C (2007) Tandem time-of-flight (TOF/TOF) mass spectrometry and the curved-field reflectron. J Chromatogr B 855(1):2–13
Creese AJ, Grant MM, Chapplea IAC, Cooper HJ (2011) On-line liquid chromatography neutral loss-triggered electron transfer dissociation mass spectrometry for the targeted analysis of citrullinated peptides. Anal Meth 3:259–266
De Ceuleneer M, De Wit V, Van Steendam KV, Van Niewerburgh F, Tilleman K, Deforce D (2011) Modification of citrullene residues with 2,3 butanedione facilitates their detection by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 25(11):1536–1542
Goëb V, Thomas-L'Otellier M, Daveau R, Charlionet R, Fardellone P, Le Loët X, Tron F, Gilbert D, Vittecoq O (2009) Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res Ther 11(2):R38
Grant JE, Hu J, Liu T, Jain MR, Elkabes S, Li H (2007) Post-translational modifications in the rat lumbar spinal cord in experimental autoimmune encephalomyelitis. J Proteome Res 6(7):2786–2791
Guan S, Marshall AG (1995) Ion traps for FT-ICR/MS: principles of mass spectrometry. Mass Spectrom Ion Proc 146(147):261–296
Gyorgy B, Erszebet T, Tarcsa E, Falus A, Buzas EI (2006) Citrullination: a post-translational modification in health and disease. Int J Biochem Cell Biol 38:1662–1677
Hagiwara T, Hidaka Y, Yamada M (2005) Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. Biochemistry 44(15):5827–5834
Hao G, Wang D, Gu J, Shen Q, Gross SS, Wang Y (2009) Citrullination of synthetic peptides by MS MS isocyanate loss. J Am Soc Mass Spectrom 20(4):723–727
Hardman M, Makarov A (2003) Interfacing the orbitrap mass analyzer to an electrospray ion source. Anal Chem 75(7):1699–1705
Hermansson M, Artemenko K, Ossipova E, Eriksson H, Lengqvist L, Makrygiannakis D, Catrina AI, Nicholas AP, Klareskog L (2010) MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen. Proteomics Clin Appl 4:511–518
Holm A, Rise F, Sessler N, Sollid LM, Undheim K, Fleckstein B (2006) Specific modification of peptide-bound citrulline residues. Anal Biochem 352(1):68–76
Hu Q, Noll RJ, Li H, Makarov A, Hardmanc M, Cooks RG (2005) The Orbitrap: a new mass spectrometer. J Mass Spectrom 40(4):430–443
Hu J, Qian J, Borisov O, Pan SQ, Li Y, Liu T, Deng LW, Wannemacher K, Kurnellas M, Patterson C, Elkabes S, Li H (2006) Optimized proteomic analysis of a mouse model of cerebellar dysfunction using amine-specific isobaric tags. Proteomics 6(15):4321–4334
Kind T, Fiehn O (2006) Metabolomic database annotations via query of elemental compositions: mass accuracy is insufficient even at less than 1 ppm. BMC Bioinforma 7:234–243
Kinlock A, Lundberg K et al (2008) Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 58(10):3009–3019
Knipp M, Vasak M (2000) A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citulline. Anal Biochem 286(2):257–264
Kubota K, Yoneyama-Takazawa T, Ichikawa K (2005) Determination of sites citrullinated by peptidylarginine deiminase using 18O stable isotope labeling and mass spectrometry. Rapid Commun Mass Spectrom 19(5):683–688
Kumari S, Stevens D, Kind T, Denkert C, Fiehn O (2011) Applying in-silico retention index and mass spectra matching for identification of unknown metabolites in accurate mass GC-TOF mass spectrometry. Anal Chem 83(15):5895–5902
Liu T, Donahue KC, Hu J, Kurnellas MP, Grant JE, Li H, Elkabes S (2007) Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord. J Proteome Res 6(7):2565–2575
Makarov A (2000) Electrostatic axially harmonic orbital trapping: a high-performance technique of mass analysis. Anal Chem 72(6):1156–1162
Makarov A, Denisov E, Lange O, Horning S (2006a) Dynamic range of mass accuracy in LTQ Orbitrap hybrid mass spectrometer. J Am Soc Mass Spectrom 17(7):977–982
Makarov A, Denisov E, Kholomeev A, Balschun W, Lange O, Strupat K, Horning S (2006b) Performance evaluation of a hybrid linear ion trap/orbitrap mass spectrometer. Anal Chem 78(7):2113–2120
Marshall AG, Hendrickson CL, Jackson GS (1998) Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrom Rev 17(1):1–35
Moscarello MA, Mastronardi FG, Wood DD (2007) The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res 32(2):251–256
Musse AA, Boggs JM, Harauz G (2006) Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope. Proc Natl Acad Sci U S A 103(12):4422–4427
Pitt D, Werner P, Raine CS (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6(1):67–70
Ross PL, Huang YLN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3(12):1154–1169
Sack TM, Lapp RL, Gross ML, Kimble B (1984) A method for the statistical evaluation of accurate mass measurement quality. Intl J Mass Spectrom. Ion Process 61:191–213
Senshu T, Sato T, Inoue T, Akiyama K, Asaga H (1992) Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal Biochem 203(1):94–100
Senshu T, Akiyama K, Kan S, Asaga H, Ishigami A, Manabe M (1995) Detection of deiminated proteins in rat skin: probing with a monospecific antibody after modification of citrulline residues. J Invest Dermatol 105(2):163–169
Seward RJ, Drouin EE, Steere AC, Costello CE (2011) Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis. Mol Cell Proteomics 10(3):M110.002477
Siuzdak G (2006) The expanding role of mass spectrometry in biotechnology, 2nd edn. MCC Press, San Diego, pp 1–252
Smith RD, Anderson GA, Lipton MS, Pasa-Tolic L, Shen Y, Conrads TP, Veenstra TD, Udseth HR (2002) An accurate mass tag strategy for quantitative and high-throughput proteome measurements. Proteomics 2(5):513–523
Stanley JR, Adkins JN, Slysz GWM, Monroe E, Purvine SO, Karpievitch YV, Anderson GA, Smith RD, Dabney AR (2011) A statistical method for assessing peptide identification confidence in accurate mass and time tag proteomics. Anal Chem 83(16):6135–6140
Stensland ME, Pollmann S, Molberg O, Sollid LM, Fleckenstein B (2009) Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4. Biol Chem 390(2):99–107
Sugawara K, Yoshizawa Y, Tzeng S, Epstein WL, Fukuyama K (1998) Colorimetric determination of citrulline residues in proteins. Anal Biochem 265(1):92–96
Suzuki A, Yamada R, Yamamoto K (2007) Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann N Y Acad Sci 1108:323–339
Syka JE, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF (2004) Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A 101(26):9528–9533
Tutturen AEV, Holm A, Jorgensen M, Stadtmuller P, Rise F, Fleckenstein B (2010) A technique for the specific enrichment of citrulline-containing peptides. Anal Biochem 403(1–2):43–51
Van Beers J, Raijmakers R, Alexander LE, Stammen-Vogelzangs J, Lokate AMC, Heck A, Schasfoort RBM, Pruijn GJM (2010) Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance. Arthritis Res Ther 12(6):R219
van Venrooij WJ, Pruijn GJ (2000) Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2(4):249–251
Wanczek KP (1989) ICR spectrometry—a review of new developments in theory, instrumentation, and applications. I. 1983–1986. Int J Mass Spectrom Ion Proc 95:1–38
Webb K, Bristow T, Sargent M, Stein B (2004) Methodology for accurate mass measurement of small molecules. Best practice guide. LGC Limited, Tddington, pp 1–8
Zimmer JSD, Monroe ME, Qian WJ, Smith RD (2006) Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom Rev 25(3):450–482
Acknowledgments
Thanks to Amy Harms, Ph.D. (Leiden University) and Martha Vestling, Ph.D. (University of Wisconsin-Madison) for critical review of this article. The authors are grateful for funding support from NIH/NINDS grant NS046593 to H.L. for the continued support of a NINDS NeuroProteomics Core Facility at Rutgers University-New Jersey Medical School.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Grant, J.E., Li, H. (2014). Identifying Citrullination Sites by Mass Spectrometry. In: Nicholas, A., Bhattacharya, S. (eds) Protein Deimination in Human Health and Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8317-5_19
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8317-5_19
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8316-8
Online ISBN: 978-1-4614-8317-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)